|
 |
| home > pmps > autumn 2002 > child-resistant/senior-effective blister card - the key to patient compliance |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
This article presents an overview of the thought process typically used to select the proper therapy for a disease state. It shows the deductive reasoning and rationalisation used for each decision. Despite this care, the rate of non-compliance with prescribed regimens is 50 per cent or more and this non-compliance adds to the costs of medical care. Through use of a properly constructed child-resistant/senior effective blister card, compliance with the therapeutic regime can be improved. With improved compliance comes a decrease in health care costs and an increase in quality of life.
Also highlighted in this article are the potential benefits that society stands to gain from the use of child-resistant packaging, for instance the prevention of poisonings and the decrease in related deaths.
Child-Resistant/Senior Effective Blister Card
Despite press reports and opinions to the contrary, most physicians, nurses, pharmacists and caregivers must overcome a plethora of obstacles to ensure that the medical delivery system is the best it can be. Compliance with prescribed and selected regimes is the goal of these medical providers, although the definition of medication compliance has become more and more precise over time.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Dr Joseph Urban, Senior Director of Technology, ProClinical Pharmaceutical Services, Inc
Dr Joseph Urban is the Senior Director of Technology for ProClinical Pharmaceutical Services, Inc. He received his BS in Pharmacy from the Philadelphia College of Pharmacy and Science, his MBA from St Joseph's University and his Doctorate of Pharmacy from Shenandoah University.
Prior to his position at ProClinical, Joseph spent seven years as Director of Clinical Supplies for the Robert Wood Johnson Pharmaceutical Research Institute and 20 years at Hoechst-Roussel Pharmaceuticals holding various positions in product development. Joseph is a member of the American Pharmaceutical Association, The International Society of Manufacturing Engineers and the Healthcare Compliance Packaging Council. He is an inventor, having been granted 12 patents, and a speaker on the topics of child-resistant packaging, clinical supplies, medication and treatment compliance and pharmaceutical development. Joseph still practices retail pharmacy and is also a Consultant Pharmacist.
|
|
|
|
|
|
 |
Industry Events |
 |
7th Annual Pharma Packaging and Labelling conference
17 September - 18 October 2008, Barcelona
7th Annual Pharma Packaging and Labelling conference will bring
together experts from leading pharma manufacturers to present case study driven
presentations on critical industry-wide issues.
Attending this event will give you an opportunity to discuss with fellow
packaging and labelling professionals and share your views on these important
matters.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
